Eli Lilly and Company (NYSE:LLY) is included among the 16 Best Dividend Stocks with Rising Payouts. According to a Reuters ...

According to MarketsandMarkets™, the Preparative and Process Chromatography Market is projected to grow from about USD 14.32 ...

Vascular Endothelial Growth Factor Inhibitor market grows 4.0% CAGR as biosimilars and personalized medicine expand ...

GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life ...

Merck announces positive new data for Enflonsia for infants and children under 2 years of age at increased risk for severe RSV disease over two RSV seasons: Rahway, New Jersey Sat ...

According to MarketsandMarkets, the Preparative and Process Chromatography Market is projected to grow from about USD 14.32 billion in 2026 ...

Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI responseDurable Clinical Observations ...

Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader ...

The government said the flagship manufacturing incentive scheme has helped boost exports, jobs and domestic value addition as ...

Over 95% of the world's adult population is infected with Epstein-Barr virus (EBV), but most people never realize it. The infection often causes few symptoms and then stays in the body for life.

Adults with primary membranous nephropathy achieved higher complete remission rates with obinutuzumab than tacrolimus in the pivotal phase 3 MAJESTY trial.

The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV ...